Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE (Tables)

v3.24.3
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Numerator:
Net loss and comprehensive loss $ (16,016) $ (20,622) $ (36,309) $ (47,098)
Denominator:
Weighted-average shares of common stock - basic and diluted
195,165,913  195,128,096  195,145,417  194,649,053 
Loss per common share:
Basic and diluted
$ (0.08) $ (0.11) $ (0.19) $ (0.24)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three and nine months ended September 30, 2024 and 2023, because the impact of including them would have been anti-dilutive:
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Stock options 26,537,311  29,664,683  27,402,967  29,185,375 
Warrants (derivative liabilities and equity) 101,726,848  86,241,092  92,766,898  86,110,330 
Unvested restricted stock awards 1,679  4,177  1,800  496,567 
128,265,838  115,909,952  120,171,665  115,792,272